Cancer Research Trials For Prevention & Treatment of Cancer

The McLeod Cancer Research Department has made national state-of-the-art cancer research trials available to eligible patients. For the past 30 years, these research trials have helped in both the prevention and treatment of cancers.

Our research department has more than 100 patients involved in cancer studies and patients can enroll in 20 to 25 protocols.

McLeod’s participation in cancer research is supported through its association with the Southeast Clinical Oncology Research Consortium (SCOR), a group of community hospitals in North Carolina, South Carolina, Georgia, Virginia and Tennessee. We also have alliances with major oncology groups and programs. For a list of clinical trials we offer through SCOR, click here.

McLeod Health recently joined Guardian Research Network (GRN), a nationwide healthcare system research consortium, to enhance the research efforts of McLeod by bringing more novel diagnostic and treatment options to patients in northeastern South Carolina and southeastern North Carolina. To learn more about GRN, click here.

  • McLeod Collaborates With Renowned Alliances

    McLeod collaborates in research with national cancer alliances and research centers including:

    • National Cancer Institute (NCI)
    • Southwest Oncology Group
    • Sun Coast Community Clinical Oncology Program
    • Cancer Trials Support Unit
    • The Alliance for Clinical Trials in Oncology
    • NRG which consists of the National Surgical Adjuvant Breast and Bowel Project (NSABP), the Radiation Therapy Oncology Group (RTOG), and the Gynecologic Oncology Group (GOG)
    • Comprehensive Cancer Center of Wake Forest University
    • The University of Rochester Cancer Center
  • More than 20 Areas of Clinical Trials

    Areas of cancer clinical research available at McLeod include: Brain Cancer, Breast Cancer, Head & Neck Cancer, Leukemia, Pancreatic Cancer, Prostate Cancer, Sarcoma, Small or Non-Small Cell Lung Cancer and Smoking Cessation.